Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
In the last 90 days, Oramed Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Holders of 5% or more of ORMP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Oramed Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Kidron Nadav | 13D/A | 7.60%3.12M shares | – | Aug 28, 20251 filing | Aug 28, 2025 | SEC |
| Aquamarine Financial (Cayman) Ltd | 13G/A | 6.04%2.51M shares | +0.98 ppfrom 5.06% | May 15, 20262 filings | Aug 14, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Oramed Pharmaceuticals Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 202611:52 AM ET | Aquamarine Financial (Cayman) Ltd | 13G/A | 6.04%2.51M shares | +0.98 ppfrom 5.06% | Jun 30, 2026 | SEC |
| Jun 29, 202610:33 AM ET | BML Investment Partners, L.P.and 1 other | 13G/A | 2.50%1.03M shares | −5.80 ppfrom 8.30%Below 5% | Jun 26, 2026 | SEC |
| May 15, 202612:07 PM ET | Aquamarine Financial (Cayman) Ltd | 13G | 5.06%2.05M shares | New | Jan 14, 2026 | SEC |
| Feb 9, 20262:13 PM ET | BML Investment Partners, L.P.and 1 other | 13G/A | 8.30%3.29M shares | +1.75 ppfrom 6.55% | Dec 31, 2025 | SEC |
| Aug 28, 20254:01 PM ET | Kidron Nadav | 13D/A | 7.60%3.12M shares | – | Feb 11, 2025 | SEC |
| Feb 13, 20254:41 PM ET | BML Investment Partners, L.P. | 13G/A | 6.55%2.64M shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Oramed Pharmaceuticals Inc. shares.
No Form 144 notices for Oramed Pharmaceuticals Inc. are on file.